Suppr超能文献

载脂蛋白E基因多态性对血液透析患者血脂、脂蛋白及动脉粥样硬化的影响。

Effect of apolipoprotein E polymorphism on serum lipid, lipoproteins, and atherosclerosis in hemodialysis patients.

作者信息

Güz G, Nurhan Ozdemir F, Sezer S, Işiklar I, Arat Z, Turan M, Haberal M

机构信息

Departments of Nephrology and Immunology, and the Hemodialysis Unit, Baskent University Faculty of Medicine, Ankara, Turkey.

出版信息

Am J Kidney Dis. 2000 Oct;36(4):826-36. doi: 10.1053/ajkd.2000.17682.

Abstract

Atherosclerosis and cardiovascular disease are the main causes of death in hemodialysis patients. Possession of the apolipoprotein E4 (ApoE4) allele has been associated with increased levels of serum lipids and with coronary and carotid artery atherosclerosis. We investigated the possible relationship between ApoE polymorphism and atherosclerosis risk factors in hemodialysis patients. Two hundred sixty-nine hemodialysis patients (115 women, 154 men) were included in our study. The mean patient age and mean hemodialysis duration were 45.8 +/- 15.3 years and 52.6 +/- 40.6 months, respectively. Testing was done on all patients to determine ApoE genotype and serum levels of total cholesterol (T-Cho), low-density lipoprotein (LDL-C), high-density cholesterol (HDL-C), triglyceride (TG), lipoprotein (a) (Lp[a]), intact parathormone (iPTH), and fibrinogen. ApoE genotype was identified with the polymerase chain reaction. Ultrasonographic measurement of carotid artery intima media thickness (IMT) was used to diagnose atherosclerosis. We also analyzed ApoE polymorphism and risk factors such as age, gender, duration of hemodialysis, smoking, and hypertension in relation to the presence of atherosclerosis. Serum T-Cho and LDL-C levels were higher in patients with the ApoE4/3 phenotype than in those with ApoE3/3 and ApoE3/2 phenotypes (P < 0.05). However, there was no statistically significant link between ApoE polymorphism and serum levels of TG, HDL-C, or Lp(a) (P > 0.05). Apart from a relationship with age and duration of hemodialysis (P < 0.05), we found no significant association between atherosclerosis and ApoE polymorphism or the other risk factors analyzed (P > 0.05). In conclusion, although ApoE polymorphism significantly affects serum levels of T-Cho and LDL-C in hemodialysis patients, this study indicates that ApoE polymorphism is not associated with the presence of atherosclerosis in these individuals. The high incidence of atherosclerosis in these patients underlines the need for further research on other possible causative factors.

摘要

动脉粥样硬化和心血管疾病是血液透析患者的主要死因。载脂蛋白E4(ApoE4)等位基因的存在与血脂水平升高以及冠状动脉和颈动脉粥样硬化有关。我们研究了血液透析患者中ApoE基因多态性与动脉粥样硬化危险因素之间的可能关系。我们的研究纳入了269例血液透析患者(115名女性,154名男性)。患者的平均年龄和平均血液透析时间分别为45.8±15.3岁和52.6±40.6个月。对所有患者进行检测以确定ApoE基因型以及总胆固醇(T-Cho)、低密度脂蛋白(LDL-C)、高密度胆固醇(HDL-C)、甘油三酯(TG)、脂蛋白(a)(Lp[a])、全段甲状旁腺激素(iPTH)和纤维蛋白原的血清水平。采用聚合酶链反应鉴定ApoE基因型。通过超声测量颈动脉内膜中层厚度(IMT)来诊断动脉粥样硬化。我们还分析了ApoE基因多态性以及年龄、性别、血液透析时间、吸烟和高血压等危险因素与动脉粥样硬化存在情况的关系。ApoE4/3表型患者的血清T-Cho和LDL-C水平高于ApoE3/3和ApoE3/2表型患者(P<0.05)。然而,ApoE基因多态性与TG、HDL-C或Lp(a)的血清水平之间无统计学显著关联(P>0.05)。除了与年龄和血液透析时间有关(P<0.05)外,我们发现动脉粥样硬化与ApoE基因多态性或所分析的其他危险因素之间无显著关联(P>0.05)。总之,虽然ApoE基因多态性显著影响血液透析患者的血清T-Cho和LDL-C水平,但本研究表明ApoE基因多态性与这些个体的动脉粥样硬化存在情况无关。这些患者中动脉粥样硬化的高发病率突出了对其他可能致病因素进行进一步研究的必要性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验